DIFFERENTIAL EXPRESSION OF VIRAL AND HUMAN INTERLEUKIN-10 (IL-10) BY PRIMARY B-CELL TUMORS AND B-CELL LINES

被引:54
作者
STEWART, JP
BEHM, FG
ARRAND, JR
ROONEY, CM
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT PATHOL, MEMPHIS, TN 38101 USA
[2] CHRISTIE CRC CANC CTR, PATERSON INST CANC RES, DEPT MOLEC BIOL, MANCHESTER M20 9BX, LANCS, ENGLAND
[3] UNIV TENNESSEE, DEPT PATHOL, MEMPHIS, TN USA
关键词
D O I
10.1006/viro.1994.1236
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human and viral interleukin-10 (IL-10) possess growth factor activity for human B cells and may act as autocrine growth factors in B cell malignancies. To study this possibility we have measured viral (v) and human (h) IL-10 expression in EBV-positive and negative B lineage tumors and tumor cell lines. Previous studies demonstrated IL-10 expression in cell lines and now we describe the pattern of IL-10 expression in primary Burkitt's lymphoma (BL) tumor biopsies and in BL lines of defined phenotypes, vIL-10 was expressed during the lytic (productive) phase of EBV infection, but not during virus latency. Although hIL-10 was expressed in the majority of B cell lines, it was not expressed in two BL biopsy specimens. Expression of hIL-10 did not correlate with the presence of EBV, but was associated with the differentiation stare of the B cell line. Thus, vIL-10 may enhance the persistence of B cells infected at sites of virus replication, and while hIL-10 may be a factor in the growth both in vivo and in vitro of some BLs and EBV-transformed B cells, it is not an absolute requirement. (C) 1994 Academic Press, Inc.
引用
收藏
页码:724 / 732
页数:9
相关论文
共 50 条
[31]   INTERLEUKIN-4 AND INTERLEUKIN-6 RECEPTOR EXPRESSION ON B-CELL LINES AND THE LYMPHOCYTES OF PATIENTS WITH B-CELL MALIGNANCIES [J].
BROWN, RD ;
GORENC, B ;
GIBSON, J ;
WARBURTON, P ;
JOSHUA, D .
LEUKEMIA & LYMPHOMA, 1992, 6 (4-5) :377-383
[32]   Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma [J].
Yang Song ;
Wei Zhang ;
Li Zhang ;
Wei Wu ;
Yan Zhang ;
Xiao Han ;
Chen Yang ;
Lu Zhang ;
Daobin Zhou .
Scientific Reports, 6
[33]   Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma [J].
Song, Yang ;
Zhang, Wei ;
Zhang, Li ;
Wu, Wei ;
Zhang, Yan ;
Han, Xiao ;
Yang, Chen ;
Zhang, Lu ;
Zhou, Daobin .
SCIENTIFIC REPORTS, 2016, 6
[34]   CDB+ B-CELL EXPRESSION BY EBV TRANSFORMED B-CELL LINES [J].
MCCURDY, DK ;
BUROTTO, F ;
ARORA, Y .
CLINICAL RESEARCH, 1990, 38 (01) :A181-A181
[35]   INTERLEUKIN-10 (IL-10) IN HUMAN-MILK [J].
GAROFALO, R ;
CHHEDA, S ;
MEI, F ;
PALKOWETZ, KH ;
RUDLOFF, HE ;
SCHMALSTIEG, FC ;
GOLDMAN, AS .
PEDIATRIC RESEARCH, 1994, 35 (04) :A11-A11
[36]   INTERLEUKIN-10 (IL-10) IN HUMAN-MILK [J].
GAROFALO, R ;
CHHEDA, S ;
RASSIN, DK ;
MEI, F ;
PALKOWETZ, KH ;
GOLDMAN, AS .
FASEB JOURNAL, 1995, 9 (03) :A287-A287
[37]   Are Interleukin-10 (IL-10) and glucose metabolism modifications linked in early prognostication of diffuse large B-cell lymphoma (DLBCL)? A multicentric, prospectic, pilot study. [J].
Seghezzi, S. ;
Ottobrini, L. ;
Moro, A. ;
Ucci, G. ;
Bertolini, A. ;
Uziel, L. ;
Lucignani, G. ;
Tagliabue, L. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 :S371-S372
[38]   Interleukin-10-producing B-cell populations in melanoma [J].
Egbuniwe, I. U. ;
Mohamad, M. -H. ;
Karagiannis, S. N. ;
Nestle, F. O. ;
Lacy, K. E. .
BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04) :e35-e35
[39]   PET/FDG and Interleukin-10 as prognostic indicators in Diffuse Large Type B-Cell Lymphoma [J].
Tagliabue, L. ;
Ottobrini, L. ;
Colombo, C. B. ;
Seghezzi, S. ;
Libani, I. ;
Moro, A. ;
Violati, M. ;
De Fazio, L. ;
Bertolini, A. ;
Foa, P. ;
Lucignani, G. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 :S153-S153
[40]   INFLUENCE OF RECOMBINANT HUMAN INTERLEUKIN-10 (IL-10) ON THE CLONAL GROWTH OF HUMAN-MALIGNANT LYMPHOID-CELL LINES AND CELL-LINES FROM HUMAN SOLID TUMORS IN-VITRO [J].
BERDEL, WE ;
OELMANN, E ;
PAPADIMITRIOU, CA ;
KOENIGSMANN, M ;
REUFI, B ;
OBERBERG, D ;
THIEL, E .
ONKOLOGIE, 1994, 17 (03) :280-283